Patents by Inventor Luz Sanguansri
Luz Sanguansri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220273571Abstract: The present invention provides compositions and products comprising a probiotic entrapped or encapsulated in a protein and carbohydrate matrix, sourced from a single non-fermented biomass and methods of producing thereof. In addition, the present invention provides methods for promoting health in a subject comprising administering a probiotic to a subject.Type: ApplicationFiled: August 6, 2020Publication date: September 1, 2022Inventors: Mary Ann AUGUSTIN, Luz SANGUANSRI, Michael CONLON, Mya Myintzu HLAING
-
Publication number: 20210100751Abstract: The invention relates to a method of producing an emulsion or suspension from a biomass. The invention also relates to producing a powder or products produced therefrom. The invention also relates to an emulsion or suspension produced by a method as described herein. The invention also relates to a powder produced by a method as described herein or products produced therefrom.Type: ApplicationFiled: February 1, 2019Publication date: April 8, 2021Inventors: Mary Ann AUGUSTIN, Luz SANGUANSRI
-
Patent number: 10785991Abstract: A method of preparing an encapsulated phospholipid oil-in-water emulsion comprising: preparing an oil-in-water pre-emulsion comprising a phospholipid-containing oil and mixing the oil-in-water pre-emulsion with an encapsulant material.Type: GrantFiled: July 12, 2013Date of Patent: September 29, 2020Assignee: Commonwealth Scientific and Industrial Research OrganisationInventors: Luz Sanguansri, Mary Ann Augustin, Zhiping Shen
-
Patent number: 9592201Abstract: A micro encapsulation material for use with storage unstable, therapeutic and nutritional agents which release the therapeutic and nutritional agents in predetermined locations in the gastro intestinal tract in which the microencapsulation material is formed by combining a food grade treated carbohydrate with a water soluble food grade protein. The therapeutic and nutritional agents form an oil phase which is emulsified with the water dispersed or dissolved encapsulant to encapsulate the therapeutic and nutritional agents. These agents may be oils or oil soluble or oil dispersible. The agents that may be encapsulated include lipids (oils including oxygen sensitive oils, fatty acids, triglycerides) and oil soluble and oil dispersible ingredients (including pharmaceuticals, probiotics, protein therapeutics and bioactives). The protein used may include any film forming water soluble protein or hydrolyzed protein and includes milk proteins such as casein and its derivatives or whey proteins.Type: GrantFiled: November 22, 2004Date of Patent: March 14, 2017Assignee: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATIONInventors: Richard Head, Luz Sanguansri, Mary Ann Augustin
-
Publication number: 20160058039Abstract: A method of preparing an encapsulated phospholipid oil-in-water emulsion comprising: preparing an oil-in-water pre-emulsion comprising a phospholipid-containing oil and mixing the oil-in-water pre-emulsion with an encapsulant material.Type: ApplicationFiled: July 12, 2013Publication date: March 3, 2016Inventors: Luz Sanguansri, Mary Ann Augustin, Zhiping Shen
-
Patent number: 8871266Abstract: Probiotic microorganisms are micro encapsulated by dispersing the probiotic microorganism in an aqueous suspension of a film forming protein and a carbohydrate; in an oil in water emulsion of a film forming protein and a carbohydrate and a fat; or in an oil which is subsequently dispersed in a film forming protein and a carbohydrate. The emulsion or suspension may be dried to form a powder. The probiotic may be dispersed in oil and then emulsified with the aqueous suspension and then dried to produce an encapsulated oil be dried to produce a powder. Oil suspended probiotics may be preferred where the probiotic is water sensitive. The preferred protein is casein or whey protein and the carbohydrate may be a resistant starch or a saccharide with a reducing sugar group. Where the probiotic is oxygen sensitive the protein carbohydrate is heated to create Maillard reaction products in the encapsulating film.Type: GrantFiled: March 30, 2004Date of Patent: October 28, 2014Assignee: Commonwealth Scientific & Industrial Research OrganisationInventors: Ross Crittenden, Luz Sanguansri, Mary Ann Augustin
-
Patent number: 7374788Abstract: Oxygen sensitive oils or oils containing oil soluble oxygen sensitive substances are encapsulated in proteins which have been reacted with carbohydrates that contain reducing sugar groups. An aqueous mixture of a protein preferably casein and a carbohydrate preferably a sugar is heated within the range of 60 to 160° C. so that Maillard reaction products are formed in the aqueous mixture. The oil phase, up to 50% by weight is then emulsified with the aqueous phase to form micro encapsulated oil particles. The formation of MRP may also be done after emulsification prior to drying. The emulsions can be used as food ingredients or dried to form powders.Type: GrantFiled: April 3, 2001Date of Patent: May 20, 2008Assignee: Commonwealth Scientific & Industrial Science CentreInventors: Mary Ann Augustin, Luz Sanguansri
-
Publication number: 20080095907Abstract: Oxygen sensitive oils or oils containing oil soluble oxygen sensitive substances are encapsulated in proteins which have been reacted with carbohydrates that contain reducing sugar groups. An aqueous mixture of a protein preferably casein and a carbohydrate preferably a sugar is heated within the range of 60 to 160° C. so that Maillard reaction products are formed in the aqueous mixture. The oil phase, up to 50% by weight is then emulsified with the aqueous phase to form micro encapsulated oil particles. The formation of MRP may also be done after emulsification prior to drying. The emulsions can be used as food ingredients or dried to form powders.Type: ApplicationFiled: December 26, 2007Publication date: April 24, 2008Inventors: Mary Augustin, Luz Sanguansri
-
Publication number: 20070218125Abstract: A micro encapsulation material for use with storage unstable, therapeutic and nutritional agents which release the therapeutic and nutritional agents in predetermined locations in the gastro intestinal tract in which the microencapsulation material is formed by combining a food grade treated carbohydrate with a water soluble food grade protein. The therapeutic and nutritional agents form an oil phase which is emulsified with the water dispersed or dissolved encapsulant to encapsulate the therapeutic and nutritional agents. These agents may be oils or oil soluble or oil dispersible. The agents that may be encapsulated Include lipids (oils Including oxygen sensitive oils, fatty acids, triglycerides) and oil soluble and oil dispersible ingredients (including pharmaceuticals, probiotics, protein therapeutics and bioactives). The protein used may include any film forming water soluble protein or hydrolysed protein and includes milk proteins such as casein and its derivatives or whey proteins.Type: ApplicationFiled: November 22, 2004Publication date: September 20, 2007Inventors: Richard Head, Luz Sanguansri, Mary Ann Augustin
-
Publication number: 20070122397Abstract: Probiotic microorganisms are micro encapsulated by dispersing the probiotic microorganism in an aqueous suspension of a film forming protein and a carbohydrate; in an oil in water emulsion of a film forming protein and a carbohydrate and a fat; or in an oil which is subsequently dispersed in a film forming protein and a carbohydrate. The emulsion or suspension may be dried to form a powder. The probiotic may be dispersed in oil and then emulsified with the aqueous suspension and then dried to produce an encapsulated oil be dried to produce a powder. Oil suspended probiotics may be preferred where the probiotic is water sensitive. The preferred protein is casein or whey protein and the carbohydrate may be a resistant starch or a saccharide with a reducing sugar group. Where the probiotic is oxygen sensitive the protein carbohydrate is heated to create Maillard reaction products in the encapsulating film.Type: ApplicationFiled: March 30, 2004Publication date: May 31, 2007Inventors: Luz Sanguansri, Mary Ann Augustin, Ross Crittenden
-
Publication number: 20030185960Abstract: Oxygen sensitive oils or oils containing oil soluble oxygen sensitive substances are encapsulated in proteins which have been reacted with carbohydrates that contain reducing sugar groups. An aqueous mixture of a protein preferably casein and a carbohydrate preferably a sugar is heated within the range of 60 to 160° C. so that Maillard reaction products are formed in the aqueous mixture. The oil phase, up to 50% by weight is then emulsified with the aqueous phase to form micro encapsulated oil particles. The formation of MRP may also be done after emulsification prior to drying.Type: ApplicationFiled: October 3, 2002Publication date: October 2, 2003Inventors: Mary Ann Augustin, Luz Sanguansri